Patent details
EP1507529 Title: COMBINATION COMPRISING VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE
Basic Information
- Publication number:
- EP1507529
- PCT Application Number:
- PCT/EP/2003/005180
- Type:
- European Patent Granted for LU
- Legal Status:
- Revoked
- Application number:
- EP037323979
- PCT Publication Number:
- WO/2003/097045
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION COMPRISING VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE
- French Title of Invention:
- COMBINAISON COMPRENANT VALSARTANE, AMLODIPINE ET HYDROCHLOROTHIAZIDE
- German Title of Invention:
- KOMBINATION ENTHALTEND VALSARTAN, AMLODIPIN UND HYDROCHLOROTHIAZID
- SPC Number:
Dates
- Filing date:
- 16/05/2003
- Grant date:
- 22/04/2009
- EP Publication Date:
- 22/04/2009
- PCT Publication Date:
- 27/11/2003
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 23/02/2005
- EP B1 Publication Date:
- 22/04/2009
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 16/05/2023
- Renunciation date:
- Revocation date:
- 29/10/2011
- Annulment date:
Owner
- From:
- 10/12/2009
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
- Name:
- Novartis Pharma GmbH
- Address:
- Brunner Strasse 59, 1230 Wien, Austria (AT)
Inventor
1
- Name:
- WEBB Randy, Lee
- Address:
- United States (US)
2
- Name:
- SHETTY Suraj, Shivappa
- Address:
- United States (US)
Priority
- Priority Number:
- 381547 P
- Priority Date:
- 17/05/2002
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/4184;
| Filing date | Document type | Number of pages |
|---|